In this episode, Mark talks with Chris Garabedian, Chairman and CEO of Xontogeny, which he founded in 2016 to support multiple promising technologies from early development through clinical proof of concept. In 2017, Chris joined Perceptive Advisors to develop their Venture Fund strategy and launched the Perceptive Xontogeny Venture Fund in 2018 to support…
Read MoreIn this week’s episode, John Younger, MD, Vice President for Science and Technology at University City Science Center in Philadelphia, PA, shares his expert perspectives as a physician-scientist and biotech entrepreneur. Drawing upon his unique blend of skills and experience, John discusses: The main ingredients of a winning pitch from startups to potential investors…
Read MoreHugo Cabrera is a biotech entrepreneur with a passion for research and development and innovation in the field of Advanced Therapy Medicinal Products (ATMPs) including cell therapy and tissue engineering. Hugo is currently Director of Business Development for Techlife, a clinical-stage biotech company, part of the São Lucas Cell Therapy Group. The São Lucas…
Read MoreDr. Crystal Icenhour is the founding CEO of Aperiomix, a precision infection testing company at the intersection of high tech and biotech. Aperiomics is a service company identifying every known bacteria, DNA virus, parasite, and fungus in one test. This technology is a novel combination of genomics and informatics transforming infectious disease diagnostics and…
Read More